One of the biggest operational challenges for pharmaceutical and biotechnology firms today is the shortage of APIs. The consequences ripple out to impact clinical development schedules, regulatory events, commercialization dates and portfolio performance. Reactive supply chain management may not be sufficient to respond to the growing supply chain complexity and disruption in the world. By contrast, businesses who make use of predictive supplier data can spot dangers in advance, enhance sourcing approaches and boost development continuity. More Info: https://clival.com/blog/how-to-prevent-api-shortages-using-predictive-supplier-insights